ÂÜÀòÂÒÂ×

The Scientific Team at Carisma Therapeutics leads the research and development of CAR macrophages, an innovative immunotherapy targeting solid tumors. This team is composed of directors, scientists, process developers, and scientific advisors who collaborate to advance preclinical and clinical studies, optimize process development, and ensure the scientific rigor and quality of the therapeutic candidates. Their work is pivotal in driving breakthroughs in cancer treatment through cutting-edge biological and translational research.